NewsEventsReports
NewsEventsReports
Submit Content
Get the latest delivered to your inbox
Privacy Policy
  1. Home
  2. /
  3. Members
  4. /
  5. Merck & Co., Inc.

Merck & Co., Inc.

At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.merck.com and connect with us on Twitter, Facebook, Instagram, YouTube and LinkedIn.

    Merck and Ridgeback's Molnupiravir Receives U.S. FDA Emergency Use Authorization for the Treatment of High-Risk Adults With Mild to Moderate COVID-19 Image

    POSTED 

    12-28-21

    Merck and Ridgeback's Molnupiravir Receives U.S. FDA Emergency Use Authorization for the Treatment of High-Risk Adults With Mild to Moderate COVID-19

    Merck and Ridgeback Biotherapeutics announced the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for molnupiravir, an investigational oral antiviral (MK-4482, EIDD-2801).
    When the COVID-19 Pandemic Hit, Our Cafeterias Stepped up To Serve People in Need Image

    POSTED 

    12-20-21

    When the COVID-19 Pandemic Hit, Our Cafeterias Stepped up To Serve People in Need

    A meal distribution program that started at the beginning of the pandemic continues to deliver thousands of meals a week to underserved communities
    Merck Issues $1 Billion Inaugural Sustainability Bond Image

    POSTED 

    12-13-21

    Merck Issues $1 Billion Inaugural Sustainability Bond

    Merck, known as MSD outside the United States and Canada, today announced its inaugural issuance of a $1 billion sustainability bond, which was part of an $8 billion underwritten public offering of notes that closed on Dec. 10, 2021.
    Accelerating Global Access Image

    POSTED 

    12-13-21

    Accelerating Global Access

    Our company is collaborating with a range of partners to enable access for patients around the world
    All Hands on Deck Against COVID-19 Image

    POSTED 

    12-10-21

    All Hands on Deck Against COVID-19

    How every division at Merck is pitching in to address a global need
    Merck Supports Hiring Our Heroes Corporate Fellowship Program Image

    POSTED 

    12-06-21

    Merck Supports Hiring Our Heroes Corporate Fellowship Program

    We are proud to support the Hiring Our Heroes Corporate Fellowship Program, bringing fantastic members to our team!
    Creating a New World in Minecraft for Students to Explore Image

    POSTED 

    12-06-21

    Creating a New World in Minecraft for Students to Explore

    Our passion for invention isn’t limited to the health care industry and the patients we serve; it drives us to inspire the next generation of inventors. So, we created a new approach to science-based learning.
    We're Training More Diverse Investigators to Help Improve Clinical Trials Image

    POSTED 

    11-17-21

    We're Training More Diverse Investigators to Help Improve Clinical Trials

    Increasing diverse participation in clinical trials plays a crucial role in ensuring that new treatments and preventative care plans are safe and work well for people from different communities.
    Seramount Names Merck As One of the 2021 Best Companies for Dads Image

    POSTED 

    11-12-21

    Seramount Names Merck As One of the 2021 Best Companies for Dads

    Seramount (formerly Working Mother Media) revealed its fourth annual list of the 2021 Best Companies for Dads. Merck was among the top companies that earned a spot on this year’s list.
    6 Global Trends Critical to Patients During the COVID-19 Pandemic Image

    POSTED 

    10-18-21

    6 Global Trends Critical to Patients During the COVID-19 Pandemic

    Merck recently hosted an expert panel of patient advocacy leaders from around the world to discuss shifts in health care and the impact on patients during the next phases of the pandemic. Special Report: COVID-19 and the Patient Perspective summarizes the panel conversation.
    Merck & Co., Inc. Logo

    Merck & Co., Inc.

    Merck & Co., Inc.

    Can't find what you're looking for?

    Join today and get the latest delivered to your inbox

    Privacy Policy